Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1075214 Target Snapshot

5'-nucleotidase · SINGLE PROTEIN · Rattus norvegicus

222Compounds
28Assays
0Approved Drugs
179.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P21588. Use UniProt P21588 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P21588 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5'-nucleotidase as ChEMBL target CHEMBL1075214, mapped to UniProt P21588. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5'-nucleotidase
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL1075214
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P21588
5'-nucleotidase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5'-nucleotidase is the right protein anchor across sources, using UniProt P21588 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5'-nucleotidase
UniProt AccessionP21588
Component TypeProtein
Sequence Length576 aa

5'-nucleotidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5'-nucleotidase, mapped to UniProt P21588. Sequence length is 576 aa.

Mapped IDP21588
Review name5'-nucleotidase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Phase III
1
Phase 0.5
Assay Mix

Activity Type Distribution

IC5059.0
KI120.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4452072 9.13 Ki 0.746 Preclinical
CHEMBL598619 9.06 Ki 0.87 Preclinical
CHEMBL14830 9.04 Ki 0.91 Preclinical
CHEMBL4443977 8.44 Ki 3.67 Preclinical
CHEMBL2408703 8.33 Ki 4.7 Preclinical
CHEMBL4483379 7.86 Ki 13.9 Preclinical
CHEMBL3606064 7.83 Ki 14.8 Preclinical
CHEMBL4585872 7.82 Ki 15.1 Preclinical
CHEMBL4475460 7.73 Ki 18.6 Preclinical
CHEMBL4443094 7.73 Ki 18.8 Preclinical
Distribution

pChEMBL Value Distribution

21
5.0
30
5.5
21
6.0
25
6.5
16
7.0
10
7.5
2
8.0
0
8.5
4
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

28
Total Assays
131
Tested Compounds
1
Assay Types
Binding — 28 assays, 131 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 18 109 6.2
single protein format 8 22 5.7
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine